The complex interactions between Aβ, tau, and NVU components highlight the multifaceted nature of AD pathogenesis, emphasizing the need for novel therapeutic approaches targeting NVU dysfunction [97,100]. This evidence concerns the gene MAPT and Alzheimer disease.